Author
M. Heinaniemi
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2019-2023 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 35 mutual co-author links6 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
Pan-cancer scale screening reveals NRF2 associated immunoevasive characteristics in non-small cell lung cancer and squamous malignancies
J. Harkonen, P. Polonen, A. Jawahar-Deen…·A.-L. Levonen
This paper identifies NRF2-associated immunoevasive features in NSCLC and squamous cancers, linking NRF2 activity to immune-cold phenotypes and potential biomarkers for immune checkpoint response.
DOI 10.1101/2022.05.15.489654 - Cancer BiologyGenome MedicinePeer-reviewed
Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1 positive pediatric leukemia identifies drug-targetable transcription factor activities
J. Mehtonen, S. Teppo, M. Lahnalampi…·M. Heinaniemi
This study uses scRNA-seq to analyze B-lymphoid differentiation and leukemic cell states in ETV6-RUNX1-positive pediatric leukemia, identifying drug-targetable transcription factor activities.
- BiochemistrybioRxiv
Radiosynthesis and Preclinical Evaluation of Ga-NOTA-Folate for PET Imaging of Folate Receptor βPositive Macrophages
O. Moisio, S. Palani, J. Virta…·A. Roivainen
This paper develops and evaluates [68Ga]Ga-NOTA-folate (68Ga-FOL) as a PET tracer for imaging FR-{beta}-positive macrophages in atherosclerosis, showing high affinity and specificity.
- Cancer BiologybioRxiv
Signaling input from divergent pathways subverts malignant B-cell transformation
L. N. Chan, M. A. Murakami, M. E. Robinson…·M. Muschen
This study shows that malignant B-cell transformation requires convergence on a single oncogenic pathway, while divergent pathways can subvert transformation and are targets for new therapeutic strategies.
DOI 10.1182/blood-2019-130774 - ImmunologybioRxiv
Immunogenomic landscape of hematological malignancies
O. Dufva, P. Polonen, O. Bruck…·S. Mustjoki
This study links immunological features to cancer subtypes, genetic alterations, and patient survival in hematological malignancies using integrated genomic and transcriptomic data.
DOI 10.1016/j.ccell.2020.06.002